SEGALL BRYANT & HAMILL, LLC

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1006378 CHICAGO, IL

Position in SUPN

as of Mar 31, 2026 · filed May 22, 2026 Compact

Position Value

$1,197,605

+$42,925 QoQ

Shares Held

23,169

-0.3% QoQ

Ownership

0.040%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2024

7 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SEGALL BRYANT & HAMILL, LLC holds $48,800,443 across 13 Drug Manufacturers - Specialty & Generic names. SUPN ranks #8 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALKS	Alkermes plc.	585,769	$20,712,791
2	NBIX	Neurocrine Biosciences Inc	56,934	$7,500,485
3	PAHC	Phibro Animal Health Corp	104,301	$5,768,888
4	AMRX	Amneal Pharmaceuticals, Inc.	277,802	$3,453,078
5	ANIP	Ani Pharmaceuticals Inc	34,834	$2,678,734
6	LQDA	Liquidia Corp	55,938	$2,111,100
7	SIGA	Siga Technologies Inc	273,522	$1,463,342
8	SUPN	Supernus Pharmaceuticals, Inc. This page	23,169	$1,197,605

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,197,605	23,169	-0.3%	Shares	Sole	2026-05-22
2025-12-31	$1,154,680	23,233	+35.5%	Shares	Sole	2026-02-13
2025-09-30	$819,311	17,144	-27.5%	Shares	Sole	2025-11-12
2025-06-30	$745,448	23,650	-6.6%	Shares	Sole	2025-08-12
2025-03-31	$829,524	25,329	0.0%	Shares	Sole	2025-05-02
2024-12-31	$915,896	25,329	-0.2%	Shares	Sole	2025-02-11
2024-09-30	$791,254	25,377	—	Shares	Sole	2024-11-08
No filing history on record for this holder in this stock.